Author: Manning Cheng

15 Dec

Posted at 16:08h in Uncategorized by
0 Likes

Vancouver, BC – GenXys Healthcare Systems Inc. (GenXys) is adding a new value dimension to Precision Genetics and the personalized health marketplace. Precision prescribing has become a leading method to bring pharmacogenetics (PGx) closer to the standard of care for certain conditions that often carry...

13 Dec

Posted at 15:42h in Patients/Healthcare Providers, Update by
1 Like

All TreatGx users now have access to the updated treatment algorithms for Post-Myocardial Infarction and Osteoporosis. As always, these updates include the TreatGx standard of providing personalized dosing based on pharmacogenetics, kidney function, liver function, and drug interactions.  Post-Myocardial Infarction This update includes recommendations from the 2013 ACCF/AHA Guidelines for...

18 Oct

Posted at 15:03h in Patients/Healthcare Providers, Update by
1 Like

All TreatGx users now have access to the updated treatment algorithm for Diabetes Mellitus Type 2. Diabetes Mellitus Type 2  This comprehensive update accounts for revisions made to existing clinical guidelines that will help health care providers select the safest and most effective medications with their patients. This update follows the recommendations...

21 Sep

Posted at 09:24h in Uncategorized by
0 Likes

Vancouver, BC – GenXys Health Care Systems (GenXys), the award-winning precision prescribing company, today announced a partnership with Helix, a leading population genomics company working at the intersection of clinical care, research, and genomics. Together, the companies will be working to ensure that “trial-and-error” prescribing...